Skip to main content
Have a personal or library account? Click to login
Urine and bladder washing cytology for detection of urothelial carcinoma: standard test with new possibilities Cover

Urine and bladder washing cytology for detection of urothelial carcinoma: standard test with new possibilities

Open Access
|Sep 2010

References

  1. Grunze H, Springss AI.. Darmstadt: G-I-T Verlag Ernst Giebler; 1980.
  2. Koss LG. The lower urinary tract in the absence of cancer. In: Koss LG, Melamed MR, editors.. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 738-776.
  3. Grossfeld GD, Litwin MS, Wolf JS Jr, Hirack H, Shuler CL, Agerter DC, et al. Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association best practice policy - part I: definition, detection, prevalence, and etiology.2001;: 599-603.
  4. Grossfeld GD, Litwin MS, Wolf JS Jr, Hirack H, Shuler CL, Agerter DC, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy - part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up.2001;: 604-10.
  5. Koss LG. Tumors of the urinary tract in urine and brushings. In: Koss LG, Melamed MR, editors.. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 777-846.
  6. Rosenthal DL, Raab SS. Cytologic detection of urothelial lesions. In: Rosenthal DL, editors.. New York: Springer; 2005. p. 57-62.
  7. Lopes-Beltran A, Sauter G, Gasser T, Hartman A, Schmitz-Dräger BJ, Helpap B, et al. Infiltrating urothelial carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors.. Lyon: IARC Press; 2004. p. 93-109.
  8. Sauter G, Algaba F, Amin MB, Busch C, Cheville J, Gasser T, et al. Noninvasive urothelial tumors. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors.. Lyon: IARC Press; 2004. p.110-9.
  9. Bastacky S, Ibrahim S, Wilczynski SP, Murphy WM. The accuracy of urinary cytology in daily practice.1999;: 118-28.
  10. Curry JL, Wojcik EM. The effect of the current World Health Organisation/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.2002;: 140-5.
  11. Greene LF, Hanash KA, Farrow GM. Benign papilloma or papillary carcinoma of the bladder?1973;: 205-7.
  12. Ross JS, Cohen MB. Ancillary methods for the detection of reccurent urothelial neoplasia.2000;: 75-86.
  13. Us-Krašovec M. Pretočna in slikovna citometrija: novi kvantitativni metodi.1998;: 40-2.
  14. Böcking A, Striepecke E, Auer H, Füzesi L. Static DNA cytometry. Biological background, technique and diagnostic interpretation. In: Wied GL, Bartels PH, Rosenthal D, Schenk U, editors.. Chicago: Tutorials of cytology; 1994. p. 107-28.
  15. Tribukait B. Flow cytometry in assessing the clinical agressiveness of genitourinary neoplasms.1987;: 108-22.
  16. Sullivan PS, Nooraie F, Sanchez H, Hirschowitz S, Levin M, Rao PN, et al. Comparison of ImmunoCyt, UroVysion and urine cytology in detection of recurrent urothelial carcinoma: a "split-sample" study.2009;: 167-73.
  17. Tętu B. Diagnosis of urothelial carcinoma from urine.2009;: S53-9.
  18. Soloway MS, Briggman V, Carpinito GA, Chodak GW, Church PA, Lamm DL, et al. Use of a new tumor marker, urinary NMP22, in the detection of occult and rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment.1996;: 363-7.
  19. Nguyen CT, Jones JS. Defining the role of NMP22 in bladder cancer surveillance.2008;: 51-8.
  20. Richter J, Beffa L, Wagner U, Schraml P, Gasser TC, Moch H, et al. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization.1998;: 1615-21.
  21. Zhao J, Richter J, Wagner U, Roth B, Schraml P, Zellweger T, et al. Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa).1999;: 4658-61.
  22. Sokolova IA, Halling KC, Jenkins RB, Burkhardt HM, Meyer RG, Seeling SA, et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.2000;: 116-23.
  23. Bubendorf L, Grilli B, Sauter G, Mihatsch MJ, Gaser TC, Dalquen P. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.2001;: 79-86.
  24. Yoder BJ, Skacel M, Hedgepeth R, Babineau D, Ulchaker JC, Liou LS, et al. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative cytology: a prospective study with focus on the natural history of anticipatory positive findings.2007;: 295-301.
  25. Kipp BR, Tanasescu M, Else TA, Bryant SC, Karnes RJ, Sebo TJ, et al. Quantitative fluorescent in situ hybridisation and its ability to predict bladder cancer recurrence and progression to muscle invasive bladder cancer.2009;: 148-54.
  26. Halling KC, Kipp BR. Fluorescence in situ hybridization in diagnostic cytology.2007;: 1137-44.
  27. Schmitt FC, Longatto-Filho A, Valent A, Vielh P. Molecular techniques in cytopathology practice.2008;: 258-67.
  28. Cancer Registry of Slovenia.. Report No. 48. Ljubljana: Institute of Oncology; 2009.
DOI: https://doi.org/10.2478/v10019-010-0042-8 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 207 - 214
Published on: Sep 29, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2010 Margareta Flezar, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.